J&J Units File Fourth Patent Suit Over Opsumit Generic
Two units of U.S. pharmaceutical giant Johnson & Johnson have hit Australian generic drugmaker Lupin AU with a patent infringement suit in the Federal Court over Lupin's generic version of blood...To view the full article, register now.
Already a subscriber? Click here to view full article